Archives of Virology

, Volume 154, Issue 7, pp 1021–1026

Establishment of cell lines using a doxycycline-inducible gene expression system to regulate expression of hepatitis B virus X protein

  • Hong Tang
  • Li Liu
  • Feng-Jun Liu
  • En-Qiang Chen
  • Seishi Murakami
  • Yong Lin
  • Fang He
  • Tao-You Zhou
  • Fei-Jun Huang
Original Article

Abstract

The hepatitis B virus (HBV) X gene plays an important role in HBV-associated pathogenesis, especially hepatocarcinogenesis. Establishment of a stable and regulable HBx expression system will allow study of the function of this gene. Here, we describe the development of a doxycycline-inducible recombinant plasmid (pBPSTR3-FlagX) with the full-length HBV X gene and all components of the tetracycline-on (“Tet-on”) gene expression system. This vector exhibited dose-dependent doxycycline-dependent induction of the Flag-HBx protein in HepG2 and Hep3B cells. We also observed dose-dependent doxycycline transactivation of HBx in HepG2 cells. After transfecting HepG2 cells with the pBPSTR3-FlagX plasmid, we isolated five puromycin-resistant cell clones with stable HBx expression, two of which exhibited stable and tight control of HBx expression by doxycycline. This new system has great potential for functional studies of the HBV X gene.

References

  1. 1.
    Bouchard MJ, Wang L, Schneider RJ (2007) Activation of focal adhesion kinase by hepatitis B virus HBx protein: multiple functions in viral replication. J Virol 80:4406–4414CrossRefGoogle Scholar
  2. 2.
    Cougot D, Neuveut C, Buendia MA (2005) HBV induced carcinogenesis. J Clin Virol 34:S75–S78PubMedCrossRefGoogle Scholar
  3. 3.
    Feitelson MA, Lee J (2007) Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis. Cancer Lett 252:157–170PubMedCrossRefGoogle Scholar
  4. 4.
    Gossen M, Bujard H (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89:5547–5551PubMedCrossRefGoogle Scholar
  5. 5.
    Heathcote EJ (2007) Treatment of hepatitis B: the next five years. Clin Med 7:472–477PubMedGoogle Scholar
  6. 6.
    Henkler F, Hoare J, Waseem N, Goldin RD, McGarvey MJ, Koshy R, King IA (2001) Intracellular localization of the hepatitis B virus HBx protein. J Gen Virol 82:871–882PubMedGoogle Scholar
  7. 7.
    Kan QC, Yu ZJ, Lei YC, Hao LJ, Yang DL (2003) Lethiferous effects of a recombinant vector carrying thymidine kinase suicide gene on 2.2.15 cells via a self-modulating mechanism. World J Gastroenterol 9:2216–2220PubMedGoogle Scholar
  8. 8.
    Lewandoski M (2001) Conditional control of gene expression in the mouse. Nat Rev Genet 2:743–755PubMedCrossRefGoogle Scholar
  9. 9.
    Lok AS (2000) Hepatitis B infection: pathogenesis and management. J Hepatol 32:89–97PubMedCrossRefGoogle Scholar
  10. 10.
    Marcellin P, Castelnau C, Martinot-Peignoux M, Boyer N (2005) Natural history of hepatitis B. Minerva Gastroenterol Dietol 51:63–75PubMedGoogle Scholar
  11. 11.
    Murakami S (1999) Hepatitis virus X protein: structure, function and biology. Intervirology 42:81–99PubMedCrossRefGoogle Scholar
  12. 12.
    Murakami S (2001) Hepatitis B virus X protein: a multifunctional viral regulator. J Gastroenterol 36:651–660PubMedCrossRefGoogle Scholar
  13. 13.
    Paulus W, Baur I, Boyce FM, Breakefield XO, Reeves SA (1996) Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells. J Virol 70:62–67PubMedGoogle Scholar
  14. 14.
    Shin D, Kim SI, Kim M, Park M (2006) Efficient inhibition of hepatitis B virus replication by small interfering RNAs targeted to the viral X gene in mice. Virus Res 119:146–153PubMedCrossRefGoogle Scholar
  15. 15.
    Tang H, Delgermaa L, Huang F, Oishi N, Liu L, He F, Zhao LS, Murakami S (2005) The transcriptional transactivation function of HBx protein is important for its augmentation role in hepatitis B virus replication. J Virol 79:5548–5556PubMedCrossRefGoogle Scholar
  16. 16.
    Tang H, Lin Y, Qin S, Zhao LS (2002) Establishment of an in vitro cell line with HBV X gene expression which is mediated by tetracycline-regulated gene expression system. Chin J Microbiol Immunol 22:194–197Google Scholar
  17. 17.
    Vadala G, Sowa GA, Smith L, Hubert MG, Levicoff EA, Denaro V, Gilbertson LG, Kang JD (2007) Regulation of transgene expression using an inducible system for improved safety of intervertebral disc gene therapy. Spine 32:1381–1387PubMedCrossRefGoogle Scholar
  18. 18.
    Weisberg IS, Brown RS Jr, Sigal SH (2007) Hepatitis B and end-stage liver disease. Clin Liver Dis 11:893–916PubMedCrossRefGoogle Scholar
  19. 19.
    Xu R, Cai K, Zheng D, Ma H, Xu S, Fan ST (2003) Molecular therapeutics of HBV. Curr Gene Ther 3:341–355PubMedCrossRefGoogle Scholar
  20. 20.
    Yang F, Zhang Y, Cao YL, Wang SH, Liu L (2005) Establishment and utilization of a tetracycline-controlled inducible RNA interfering system to repress gene expression in chronic myelogenous leukemia cells. Acta Biochim Biophys Sin (Shanghai) 37:851–856CrossRefGoogle Scholar
  21. 21.
    Yarranton GT (1992) Inducible vectors for expression in mammalian cells. Curr Opin Biotechnol 3:506–511PubMedCrossRefGoogle Scholar
  22. 22.
    Zhang Z, Protzer U, Hu Z, Jacob J, Liang TJ (2004) Inhibition of cellular proteasome activities enhances hepadnavirus replication in an HBX-dependent manner. J Virol 78:4566–4572PubMedCrossRefGoogle Scholar
  23. 23.
    Zheng Y, Chen WL, Ma WL, Chang C, Ou JH (2007) Enhancement of gene transactivation activity of androgen receptor by hepatitis B virus X protein. Virology 363:454–461PubMedCrossRefGoogle Scholar
  24. 24.
    Zhu Z, Zheng T, Lee CG, Homer RJ, Elias JA (2002) Tetracycline-controlled transcriptional regulation systems: advances and application in transgenic animal modeling. Semin Cell Dev Biol 13:121–128PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Hong Tang
    • 1
  • Li Liu
    • 1
  • Feng-Jun Liu
    • 1
  • En-Qiang Chen
    • 1
  • Seishi Murakami
    • 2
  • Yong Lin
    • 1
  • Fang He
    • 1
  • Tao-You Zhou
    • 1
  • Fei-Jun Huang
    • 3
  1. 1.Center of Infectious Diseases, Division of Molecular Biology of Infectious DiseasesNational Key Laboratory of Biotherapy (Sichuan University), West China Hospital of Sichuan UniversityChengduPeople’s Republic of China
  2. 2.Department of Molecular Oncology, Cancer Research InstituteKanazawa UniversityKanazawaJapan
  3. 3.Department of Forensic Pathology, College of Basic Medicine and Forensic MedicineSichuan UniversityChengduPeople’s Republic of China

Personalised recommendations